The prospects oncology funds by FACIT to be invested in the Ontario-developed medical device

Three promising Ontario-based oncology advancements are beneficiaries of seed capital through the most recent round of FACITs Prospects Oncology Fund. Medical gadget fire up Xpan Inc., Dr. Igor Stagljar of the University of Toronto, and the Drug Discovery Program at the Ontario Institute for Cancer Research (OICR) were chosen to get seed subsidizing among a top-level pool of candidates. Xpan Inc., whose CEO Zaid Atto additionally won FACITs Fa....